| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 46.642 | 38.615 | 35.436 | 32.949 | 36.584 | 0 |
| Total Income - EUR | - | - | - | 27.575 | 48.561 | 38.615 | 35.497 | 36.514 | 36.584 | 0 |
| Total Expenses - EUR | - | - | - | 4.713 | 27.867 | 26.348 | 41.260 | 43.766 | 50.655 | 0 |
| Gross Profit/Loss - EUR | - | - | - | 22.862 | 20.694 | 12.267 | -5.763 | -7.252 | -14.071 | 0 |
| Net Profit/Loss - EUR | - | - | - | 22.861 | 20.596 | 12.128 | -5.918 | -7.354 | -14.071 | 0 |
| Employees | - | - | - | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Daig Giofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 7.371 | 23.952 | 16.396 | 9.088 | 2.150 | 0 | 0 |
| Current Assets | - | - | - | 27.612 | 24.021 | 42.827 | 42.875 | 33.690 | 18.110 | 48 |
| Inventories | - | - | - | 15.951 | 5.857 | 5.323 | 8.844 | 9.171 | 2.681 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 56 | 0 |
| Cash | - | - | - | 11.661 | 18.164 | 37.504 | 34.031 | 24.518 | 15.373 | 48 |
| Shareholders Funds | - | - | - | 22.904 | 43.056 | 54.368 | 47.244 | 33.953 | 16.140 | 48 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 12.080 | 4.917 | 4.856 | 4.719 | 1.886 | 1.970 | 0 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "145 - 145" | |||||||||
| CAEN Financial Year |
145
|
|||||||||
Comments - Daig Giofarm S.r.l.